EquityZen Growth Technology Fund LLC - Series 347
Raised
$95K
Investors
5
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 347 is a Delaware pooled investment vehicle filed December 19, 2018, that raised $95K from 5 investors under Rule 506(b) and Section 3(c)(1). The minimum investment was $10K. This is part of the EquityZen platform, which operates 1,891 related EDGAR entities focused on pre-IPO secondary market access.
This pre-IPO fund vehicle uses the standard 506(b)/3(c)(1) exemption structure typical of private funds with fewer than 100 beneficial owners. The $10K minimum investment represents a retail-accessible tier within the alternative investment space, significantly lower than institutional minimums, and aligns with EquityZen's model of democratizing pre-IPO access through series-based SPVs targeting individual growth-stage companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
